HLN Consulting LLC
  • About
    • About HLN
    • Our History
    • Clients
    • Careers
  • Solutions
    • Informatics Solutions
    • Case Studies
    • ICE
    • DMI
    • VPAS
  • Knowledge
    • Articles
    • Blog
    • Case Studies
    • Collaborations
    • Newsletters
    • Presentations
    • Press Releases
    • White Papers
  • Blog
  • Contact Us

BLOG
HLN updates COVID-19 vaccine support for Pfizer pediatric dose in its Award Winning ICE Open Source Immunization Forecaster

BY Lux Phatak ON November 24, 2021
AIRA | CDC | Clinical Decision Support (CDS) | COVID-19 | EHR/PHR | Immunization Calculation Engine (ICE) | Immunization Information System (IIS) | Open Source

On November 24, 2021, HLN released a new version (v1.32.1) of the Immunization Calculation Engine (ICE) in support of updates to the COVID-19 vaccine. ICE is a state-of-the-art open source software system that provides clinical decision support for immunizations for use in Immunization Information Systems (IIS), Electronic Health Record (EHR), and Personal Health Record (PHR) Systems.

Version 1.32.1 includes the following additions and updates. Please see the Release Notes for details.

  • COVID-19 Updates:
    • COVID-19 Pfizer Pediatric Dose (5 through 11 years old)
    • Evaluation of Janssen booster dose as Valid
    • Added COVAXIN (CVX 502) as a WHO-approved vaccine for EUA
  • An updated Implementation Guide with the following new codes:
    • CVX 218 – vaccine code for the COVID-19 Pfizer pediatric vaccine
    • BOOSTER_DOSE – new recommendation reason code to indicate that the recommendation is for a booster dose

The full software release is available for download at https://cdsframework.atlassian.net/wiki/spaces/ICE/pages/18972704/Downloads 

Note about upcoming ICE release (scheduled December 2021)

  • As always, HLN is actively monitoring all news and updates in regards to new and existing COVID-19 vaccines. Currently, we are working on adding additional support and logic (based on latest published guidance) in ICE to handle the following:
    • Updated Booster Dose Rules
    • Updated Additional Dose Rules
    • Updated Absolute Minimum Intervals and Absolute Minimum Ages

Plans for COVID-19 Support in ICE

Once a vaccine has been approved for use by the FDA (either Expanded Access, EUA, or full licensure), the Advisory Committee on Immunization Practices (ACIP) will hold an emergency meeting and publish recommendations in a very quick time frame (i.e., days). HLN intends to release a version of ICE that includes updated COVID-19 forecasting as early as possible. The initial release will contain COVID-19 logic that is known at the time of the release. As additional, relevant information on COVID-19 becomes available from official sources, HLN will continue to release additional versions of ICE, at appropriate times.

If you have any questions, comments or suggestions, please e-mail us at ice@hln.com.

Send us feedback about this blog

    HLN Consulting, LLC
    9 Pemberly
    Mission Viejo, CA 92692
    info@hln.com
    858-538-2220
    GSA

    Newsletter Sign-up

      Home
      About
      Solutions
      Clients
      Blog
      Careers
      Contact Us
      HLN Brochure 2020HLN Brochure
      Download ICE BrochureICE Brochure
      Knowledge & Resources
      Newsletters
      Contract Vehicles Privacy Policy Cookie Policy

      Copyright © 2023
      HLN Consulting, LLC